28 June 2010
Kidney transplantation in Afghan refugees residing in Iran: The first report of survival analysis
Maryam Moghani-Lankarani, Shervin Assari, Babak Kardavani, Behzad EinollahAnn Transplant 2010; 15(2): 55-60 :: ID: 880941
Abstract
Background: We report, for the first time, the data on the outcome of kidney transplantation activities in the Afghan population from Iran.
Material/Method: We extracted the demographic, clinical and the outcome related data of all Afghan kidney transplanted patients, from 1998 to April 2006, from the United Nations High Commissioner for Refugees (UNHCR) and the Dialysis and Transplant Patients Association (DATPA) databases.
Results: During this period 103 Afghan patients (70.9% male, 29.1% female) underwent renal transplantation in Iran. The mean age at transplantation was 32.7 years. The kidney sources were living unrelated donors (LURD) in 82.5%, living related donors (LRD) in 15.5% and cadaver in 2% patients. The graft and patient survival rates for 1, 3 and 5 years were 97 and 98, 86 and 95, 73 and 95 percent, respectively.
Conclusions: Both graft and patient survival rates were good and comparable to those reported previously in Iranian patients.
Keywords: Kidney Transplantation, Refugees, Outcome
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588